Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
142
-
Total 13F shares, excl. options
-
62M
-
Shares change
-
+165K
-
Total reported value, excl. options
-
$1.85B
-
Value change
-
-$24.6M
-
Put/Call ratio
-
0
-
Number of buys
-
65
-
Number of sells
-
-62
-
Price
-
$29.89
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2021
166 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q3 2021.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 142 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62M shares
of 107M outstanding shares and own 57.8% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (15.8M shares), WELLINGTON MANAGEMENT GROUP LLP (3.35M shares), VANGUARD GROUP INC (3.25M shares), BlackRock Inc. (3.22M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.88M shares), TANG CAPITAL MANAGEMENT LLC (2.53M shares), STATE STREET CORP (2.34M shares), PERCEPTIVE ADVISORS LLC (2.31M shares), RA CAPITAL MANAGEMENT, L.P. (2.11M shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (2.03M shares).
This table shows the top 142 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.